Ads
related to: chronic kidney disease- Treatment Information
Learn About An HF & CKD Treatment
Efficacy & Safety Data
- Dosing & Administration
Once-Daily Dosing
Information Available Online
- Savings
Savings Your Eligible
Patients Will Appreciate
- Sign Up For More Info
Stay Updated &
Register To Receive Information
- Approved For HF & CKD
Make A Life-Saving Choice For
Your Heart Failure & CKD Patients.
- Formulary Finder
Formulary Coverage
For Your Patients
- Treatment Information
Search results
Women face worse chronic kidney disease management in primary care
Medical Xpress· 21 hours agoWomen receive worse primary care-based chronic kidney disease (CKD) management than men, according...
Rila Therapeutics doses first cohort in Phase I CKD treatment trial
Clinical Trials Arena via Yahoo Finance· 6 hours agoRila Therapeutics has dosed the first cohort of subjects in a Phase I clinical trial of RLA-23174, a...
Negative link seen for oxidative balance score with chronic kidney disease
Medical Xpress· 1 day agoThere is a negative association for oxidative balance score (OBS) with chronic kidney disease,...
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management...
WTRF Wheeling· 4 days agoRenal Research Institute (RRI), a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, today announced together with the Karolinska Institutet a joint ...
Unraveling the connection between type 2 diabetes and chronic kidney disease
CBS News· 4 days agoWhen you are newly diagnosed with type 2 diabetes (T2D), many concerns, questions and emotions can...
FLOW Study, Dialysis Developments, CKD Treatment Key at ERC
Medscape· 12 hours agoThe 61st European Renal Congress to cover full gamut of nephrology news, research and practice...
... Trial of RLA-23174, a First-In-Class HIPK2 Allosteric Inhibitor, For Treatment of Chronic Kidney...
The Yuma Sun· 1 day agoRLA-23174 is a first-in-class small molecule allosteric inhibitor of HIPK2 which inhibits TGF-β signaling to address FSGS and other fibrotic diseases. RLA-23174 is a new small molecule allosteric ...
Study Identifies Several Onychomycosis Risk Factors
Medscape· 2 days agoTinea pedis, chronic kidney disease, peripheral vascular disease, and type 2 diabetes were associated with an increased risk for onychomycosis in...
Research collaboration develops lifesaving 'Ark' technology for chronic kidney disease patients
Medical Xpress· 6 days agoFood and Drug Administration-approved pivotal trial in the U.S. this fall. According to the Centers...
Gastrointestinal Bleeding More Common in Advanced CKD
MedPage Today· 2 days agoRisk was significantly higher regardless of dialysis status
